Top CEO Executive Search Firm in Mumbai for Pharma & Biotech — 2026

Mumbai is the corporate capital of Indian pharma — the headquarters of many of the country's largest, often listed, global generics, formulations and specialty-pharma companies, alongside API, biotech and a deep regulatory and commercial talent base. The CEO mandate operates at global scale: a chief executive who can run a USFDA- and EMA-facing, multi-market business, command global generics and specialty strategy, hold quality and compliance as a first principle, and — for the listed majors — lead under public-market scrutiny and through the cycles of pricing, patent and regulatory pressure that define the industry. The defining scarcity is the science-and-regulation-literate leader who can also run a global P&L and a capital-allocation agenda across markets and pipelines; the failure mode is a commercial generalist who cannot hold scientific or regulatory credibility, or a domestic operator who cannot run a global, multi-regulator business.

Compensation for listed and global pharma majors is among the most sophisticated in India — base, substantial performance-linked pay, ESOPs or RSUs and long-term incentives tied to global performance; specialty and biotech add milestone-linked elements. The brief codifies the construction. The stakeholder map runs from boards and promoters to global regulators, investors and, for the listed majors, public markets. References reach to boards, regulators and global commercial leaders, because the question that decides these mandates — can this leader run a global, multi-regulator pharma business while protecting quality — is answered by those who have watched them do it.